IL-9
IL-9 (interleukin 9, also known as HP40 or P40) is a secreted, multifunctional cytokine produced mainly by T-helper 2 lymphocytes, mast cells and NKT cells. It regulates a variety of haematopoietic cells and plays an important role in the immune response against parasites. Browse Assay Genie's current range of IL-9 research reagents below, or read on for the biology behind the target.
IL-9 is a multifunctional cytokine secreted mainly by T-helper 2 lymphocytes, and also by mast cells and NKT cells. It contributes to the immune response against parasites, affects intestinal epithelial permeability and influences adaptive immunity. It induces the differentiation of specific T-cell subsets, such as IL-17 producing helper T-cells (TH17), and drives the proliferation and differentiation of mast cells. More broadly, it stimulates cell proliferation and prevents apoptosis in haematopoietic cells.
IL-9 acts through a receptor made up of the IL9R subunit and a signal-transducing subunit, IL2RG. Receptor stimulation rapidly activates the kinases JAK1 and JAK3, which leads to transcriptional programmes mediated by STAT1, STAT3 and STAT5. Induction of differentiation genes appears to depend on STAT1 alone, whereas protection of cells from apoptosis depends on STAT3 and STAT5. This links the cytokine to a range of biological processes.
The human IL9 gene is classed by HGNC among the interleukins and the interleukin 2 family group, and the protein belongs to the IL-7/IL-9 family. It is also known as HP40 and P40. The gene has been identified as a candidate gene for asthma, and genetic studies in a mouse model of asthma showed that IL-9 is a determining factor in the pathogenesis of bronchial hyperresponsiveness. A mouse ortholog, Il9, is annotated.
The IL9 gene is a candidate gene for asthma, and mouse studies identify IL-9 as a determinant of bronchial hyperresponsiveness.
IL-9 is secreted mainly by T-helper 2 cells and plays important roles in the immune response against parasites.
IL-9 induces TH17 differentiation and drives the proliferation and differentiation of mast cells, making it relevant to lymphocyte subset studies.
IL-9 signals through IL9R and IL2RG, activating JAK1, JAK3 and STAT1, STAT3 and STAT5 to control differentiation and survival.
IL-9 is a secreted cytokine that regulates haematopoietic cells, stimulating proliferation and preventing apoptosis. It supports immune responses against parasites, affects intestinal epithelial permeability and adaptive immunity, and promotes TH17 and mast cell differentiation. Signalling occurs through IL9R and IL2RG, with JAK1, JAK3 and STAT proteins.
The HGNC gene symbol is IL9 and the approved name is interleukin 9. Aliases include HP40 and P40. UniProt lists the protein as Interleukin-9, and it belongs to the IL-7/IL-9 family. HGNC places it in the interleukin 2 family gene group.
The IL9 gene is a candidate gene for asthma. Genetic work in a mouse model of asthma showed IL-9 is a determining factor in bronchial hyperresponsiveness. The mouse ortholog is Il9; check the datasheet of any product for its validated reactivity.
Other interleukins, including IL-2 family cytokines and T-cell-derived mediators, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P15248; product specifications from Assay Genie datasheets.